<DOC>
	<DOCNO>NCT00370565</DOCNO>
	<brief_summary>To assess impact glucose control inhaled insulin alone add two oral anti-diabetic agent patient type 2 diabetes well control 2 oral anti-diabetic agent .</brief_summary>
	<brief_title>Effect Glycemic Control Inhaled Insulin Alone Added Dual Oral Therapy After Failure Dual Oral Therapy .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 Diabetes Mellitus define American Diabetes Association ( ADA ) least 1 year earlier . Patients require treated stable oral agent regimen involve 2 antidiabetc medication : 1 insulin secretagogue ( sulfonylurea replabinide ) 1 insulin sensitizer ( thiazolidinedione metformin ) . Asthma , COPD Smoking previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>